Cargando…

Characterizing Real-World Use Of Tiotropium In Asthma In The USA

BACKGROUND: Tiotropium bromide (TIO) is a long-acting muscarinic antagonist recommended as an add-on therapy option for patients with uncontrolled asthma on inhaled corticosteroids (ICS) and long-acting β(2)-agonists (LABA). However, real-world data on TIO use in asthma remains limited. To identify...

Descripción completa

Detalles Bibliográficos
Autores principales:	Averell, Carlyne M, Laliberté, François, Duh, Mei Sheng, Wu, Jennifer W, Germain, Guillaume, Faison, Sarai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789414/ https://www.ncbi.nlm.nih.gov/pubmed/31632091 http://dx.doi.org/10.2147/JAA.S216932

Ejemplares similares

Impact of adherence to treatment with inhaled corticosteroids/long-acting β-agonists on asthma outcomes in the United States
por: Averell, Carlyne M., et al.
Publicado: (2022)

Elucidating the Real-World Burden of Chronic Rhinosinusitis With Nasal Polyps in Patients in the USA
por: Benson, Victoria S., et al.
Publicado: (2022)

Real-World Healthcare Resource Utilization in Patients with Classical Hodgkin Lymphoma Treated with Pembrolizumab and Nivolumab in the USA
por: Laliberté, François, et al.
Publicado: (2020)

Real-World Study of Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol on Asthma Control in the US
por: Bogart, Michael, et al.
Publicado: (2023)

Real-World Treatment Patterns and Switching Following Moderate/Severe Chronic Obstructive Pulmonary Disease Exacerbation in Patients with Commercial or Medicare Insurance in the United States
por: Bogart, Michael, et al.
Publicado: (2023)

A 5-Year Retrospective, Observational Study Assessing Rheumatoid Arthritis Disease Outcome Measures to Characterize Systemic Lupus Erythematosus Burden in the USA
por: Bell, Christopher F., et al.
Publicado: (2022)

Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population
por: Bogart, Michael, et al.
Publicado: (2019)

Hospital Admission and Readmission Among US Patients Receiving Umeclidinium/Vilanterol or Tiotropium as Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease
por: Slade, David, et al.
Publicado: (2021)

Time-to-first exacerbation, adherence, and medical costs among US patients receiving umeclidinium/vilanterol or tiotropium as initial maintenance therapy for chronic obstructive pulmonary disease: a retrospective cohort study
por: Slade, David, et al.
Publicado: (2021)

Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities
por: Kalhan, Ravi, et al.
Publicado: (2021)

Comparing Real-World Healthcare Costs Associated with Single-Tablet Regimens for HIV-1: The 2-Drug Regimen Dolutegravir/Lamivudine vs. Standard 3- or 4-Drug Regimens
por: Priest, Julie, et al.
Publicado: (2023)

Real‐World Adherence in Patients with Metastatic Colorectal Cancer Treated with Trifluridine plus Tipiracil or Regorafenib
por: Patel, Anuj K., et al.
Publicado: (2019)

853. Real-World Persistency of Patients Receiving Tenofovir-Based Pre-Exposure Prophylaxis for the Prevention of HIV Infection in the US
por: Oglesby, Alan, et al.
Publicado: (2021)

Real‐World Characteristics, Treatment Patterns, Health Care Resource Use, and Costs of Patients with Diffuse Large B‐Cell Lymphoma in the U.S
por: Yang, Xiaoqin, et al.
Publicado: (2021)

Tiotropium Add-On and Treatable Traits in Asthma-COPD Overlap: A Real-World Pilot Study
por: Ishiura, Yoshihisa, et al.
Publicado: (2022)

The role of tiotropium in the management of asthma
por: Park, Heung-Woo
Publicado: (2012)

Safety of tiotropium in patients with asthma
por: Dusser, Daniel, et al.
Publicado: (2019)

The evolving role of tiotropium in asthma
por: McIvor, Emma R, et al.
Publicado: (2017)

Tiotropium in asthma: a systematic review
por: Befekadu, Elizabeth, et al.
Publicado: (2014)

Clinical efficacy of tiotropium in children with asthma
por: Huang, Juan, et al.
Publicado: (2016)

Observational vignette study to examine patient and healthcare provider perceived impact of asthma-related exacerbations in the US
por: Johnson, Phaedra T., et al.
Publicado: (2019)

Tiotropium in asthma: back to the future of anticholinergic treatment
por: Bonini, Matteo, et al.
Publicado: (2017)

Tiotropium for the Treatment of Asthma: Patient Selection and Perspectives
por: Chari, V. Madhu, et al.
Publicado: (2018)

PB2114: BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA: A REAL-WORLD OBSERVATIONAL STUDY UPDATE
por: Hultcrantz, Malin, et al.
Publicado: (2023)

Tiotropium in asthma: what is the evidence and how does it fit in?
por: Halpin, David M. G.
Publicado: (2016)

The evidence on tiotropium bromide in asthma: from the rationale to the bedside
por: Radovanovic, Dejan, et al.
Publicado: (2017)

Real-World Reductions in Oral Corticosteroid Use in the USA Following Mepolizumab Therapy for Severe Asthma
por: Silver, Jared, et al.
Publicado: (2020)

Clinical and Economic Burden in Patients With Systemic Lupus Erythematosus During the First Year After Initiating Oral Corticosteroids: A Retrospective US Database Study
por: DerSarkissian, Maral, et al.
Publicado: (2023)

Prolonged oral corticosteroid treatment in patients with systemic lupus erythematosus: An evaluation of 12-month economic and clinical burden
por: Huang, Shirley P, et al.
Publicado: (2023)

Tiotropium Bromide in Chronic Obstructive Pulmonary Disease and Bronchial Asthma
por: Alvarado-Gonzalez, Alcibey, et al.
Publicado: (2015)

Erratum to: The evidence on tiotropium bromide in asthma: from the rationale to the bedside
por: Radovanovic, Dejan, et al.
Publicado: (2017)

Real-world treatment patterns and effectiveness among patients with metastatic colorectal cancer treated with ziv-aflibercept in community oncology practices in the USA
por: Ivanova, Jasmina I., et al.
Publicado: (2017)

1544. HIV Following Oral Pre-Exposure Prophylaxis (PrEP) Initiation
por: Metzner, Aimee A, et al.
Publicado: (2023)

Real-world effectiveness of early intervention with fixed-dose tiotropium/olodaterol vs tiotropium in Japanese patients with COPD: a high-dimensional propensity score–matched cohort analysis
por: Muro, Shigeo, et al.
Publicado: (2021)

Tiotropium's cost-effectiveness for the treatment of COPD: a cost-utility analysis under real-world conditions
por: Neyt, Mattias, et al.
Publicado: (2010)

Tiotropium safety in ‘real‐world’ populations: Response to Schmiedl, et al. in the British Journal of Clinical Pharmacology
por: Wise, Robert, et al.
Publicado: (2016)

Real-World Treatment Patterns and Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer in the US Prior to PARP Inhibitors
por: Shore, Neal D., et al.
Publicado: (2021)

Health characteristics of patients with asthma, COPD and asthma–COPD overlap in the NHANES database
por: Llanos, Jean-Pierre, et al.
Publicado: (2018)

Characteristics of Treated Asthmatics Experiencing Exacerbations in a US Database: A Retrospective Cohort Study
por: Averell, Carlyne M, et al.
Publicado: (2021)

A randomised controlled trial of tiotropium in adolescents with severe symptomatic asthma
por: Hamelmann, Eckard, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bj69m4hfajupt4sjo5ceq2l5a1